Current State: CXL Course

BECOME A CROSS-LINKING EXPERT

This full day programme is designed to bring delegates up-to-speed on cross-linking, right up to the latest best-practices in corneal cross-linking for the treatment of ectasias and keratitis.

Principles – core cross-linking knowledge

  • Why we cross-link – our current understanding of the pathologies present in keratectasia and corneal keratitis, reviewing from the molecular and cellular level upwards.
  • How cross-linking works – the chemistry of CXL and how CXL changes the cornea to treat the underlying pathologies.

Clinics – best-practice CXL protocols and patient management
Learn what the latest thinking is (and hear the debate, first-hand) from the world’s leading cross-linking experts.

Ectasia:

  • Epi-off Dresden
  • Epi-off accelerated
  • Epi-on
  • Iontophoresis
  • Pulsed
  • Customized

Infection:

  • PACK-CXL for the treatment of infectious keratitis
Friday
December 06
Principles
Time
Session
Speaker
8.25
Welcome
Farhad Hafezi (Switzerland)
Chairs:
Cosimo Mazzotta / Francesca Gilardoni
8.30
CXL Effect I: increase in biomechanics
John Marshall (UK)
8.45
CXL Effect II: enzymatic resistance
David O'Brart (UK)
9.00
CXL Effect III: Antimicrobial effect
Francesca Gilardoni (Switzerland)
9.15
Fluence, thickness, demarcation line
Cosimo Mazzotta (Italy)
9.30
Role of oxygen, riboflavin concentration and hydration
Theo G. Seiler (Switzerland)
9.45
Biomarkers in keratoconus and cross-linking
Rohit Shetty (India)
10.00
CXL effect in corneal topography and tomography
Michael Belin (USA)
10.15
CXL effect measured by CorVis
Riccardo Vinciguerra (Italy)
10.30 - 11.00
Coffee Break
11.00
CXL effect in Brillouin microscopy
Giuliano Scarcelli (USA)
11.15
Machine learning and AI approaches to planning treatment
Stephen Klyce (USA)
11.30
Panel discussion, questions from audience
11.45–13.00
Lunch Break
Clinics: PACK-CXL
Chairs:
Shihao Chen / Simon Pot
Time
Session
Speaker
13.00
Optimizing protocols
Emilio Torres (Switzerland)
Clinics: CXL
Chairs:
Theo Seiler / Rajesh Rajpal
13.15
Epi-off “Dresden" and accelerated
Frederik Raiskup (Germany)
13.30
Epi-on
Shihao Chen (China)
13.45
Thin corneas
Farhad Hafezi (Switzerland)
14.00
Pulsed
J. Bradley Randleman (USA)
14.15
Iontophoresis
Paolo Vinciguerra (Italy)
14.30
Customized
Theo Seiler (Switzerland)
14.45
Panel discussion, questions from audience
15.00 - 15.30
Coffee Break
Free papers
Chairs:
Stephen Klyce / Emilio Torres
15.30
Specialty contact lenses for keratoconus in the era of corneal crosslinking
Carina Koppen (Belgium)
15.38
A Comparison Study of Accelerated CXL Treatment for Progressive Keratoconus in Adult Population with Thin and Normal Cornea Thickness.
Boris Knyazer (Israel)
15.46
Corneal cross-linking for progressive keratoconus: 10-year outcomes
Reyhaneh Abrishamchi (Switzerland)
15.54
Theoretical explanation of tomographic parameters of keratoconus corneas
Mirko Jankov (Russia)
16.02
Discussion
16.15
Comparison between cross-linking with mechanical epithelial debridement, transPRK and transPTK.
Jonathan Moore (UK)
16.23
Comparing long term outcomes of Topo-Guided Removal of Epithelium in Keratoconus(TREK) vs Topo-Guided Photorefractive Keratectomy with simultaneous cross linking.
Pooja Khamar (India)
16.31
Revisiting the safety of corneal collagen crosslinking procedure: Evaluation of the effect of ultraviolet-A-radiation on the retinal function and structure
Apostolos Lazaridis (Greece)
16.39
Discussion
16.50
Repeatability and Agreement of Pentacam, Galilei & Sirius in Paediatric Keratoconus and its impact on Cross-Linking.
Pooja Mehta (India)
16.58
Prevalence Of Keratoconus Among Patients Seeking Refractive Surgery In Syria
Abdelrahman Salman (Syria)
17.06
Diluted alcohol and iontophoresis-assisted epi-on corneal cross-linking versus epi-off collagen cross-linking in progressive keratoconus: 3-year clinical results.
Seher Uysal (Turkey)
17.14
Comparison of two epithelial removal techniques prior to accelerated corneal cross-linking for progressive keratoconus: Mechanical removal or transepithelial laser ablation.
Ozge Sarac (Turkey)
17.22
Discussion
17.35
End of Day 2

Pin It on Pinterest